Trevi Therapeutics, Inc. · NASDAQ:TRVI
Frazier Life Sciences Public Fund, L.P. reported a 7.00% stake in Trevi Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Frazier Life Sciences Public Fund, L.P. reported a 7.00% stake in Trevi Therapeutics, Inc., 8,508,021 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 7.00%
- Shares
- 8,508,021
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 14 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 7.00% | 8,508,021 |
| FHMLSP, L.P. | 7.00% | 8,508,021 |
| FHMLSP, L.L.C. | 7.00% | 8,508,021 |
| Frazier Life Sciences X, L.P. | 0.30% | 397,309 |
| FHMLS X, L.P. | 0.30% | 397,309 |
| FHMLS X, L.L.C. | 0.30% | 397,309 |
| Frazier Life Sciences XI, L.P. | 1.10% | 1,354,079 |
| FHMLS XI, L.P. | 1.10% | 1,354,079 |
| FHMLS XI, L.L.C. | 1.10% | 1,354,079 |
| James N. Topper | 0.30% | 397,309 |
| Patrick J. Heron | 0.30% | 397,309 |
| Albert Cha | 0% | 0 |
| James Brush | 0% | 0 |
| Daniel Estes | 0% | 0 |
Source
Related
- Trevi Therapeutics, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Trevi Therapeutics, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · May 15, 2025
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Feb 14, 2025
- Form 4 · Heffernan Michael Thomas · Sep 17, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D/A · New Enterprise Associates 16, L.P. · May 7, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026